PERSPECTA

News from every angle

← Back to headlines

Itron Q4 Performance Impacted by Regulatory Delays

Itron (ITRI) experienced setbacks in its fourth-quarter performance due to slower-than-anticipated regulatory approval processes.

16 Feb, 14:18 — 16 Feb, 14:18
PostShare
Only 1 source covers this story